Kenya | BCH-RA-KE-115659 | Risk Assessment generated by a regulatory process | Biosafety Clearing-House

Loading...
  |  
BCH-RA-KE-115659-1   |   PDF   |   Print   |  

Risk Assessment generated by a regulatory process (RA)

last updated: 16 Jun 2020
General Information
Summary risk assessment report on the application for Confined Field Trial of a novel Rift Valley Fever Vaccine in sheep, goats, cattle and camels
EN
25 Nov 2016
Risk assessment details
  • Rift Valley Fever Virus DIVA vaccine
    | International Livestock Research Institute (ILRI) /The Jenner Institute, University of Oxford, United Kingdom | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
Additional information
EN
Records referencing this document Show in search
Record type Field Record(s)
Loading...